Life Sciences Patents – Perfect Your Patent Prosecution Strategies in the U.S. and Around the World

May 16 - 17, 2019 | New York City

TO REGISTER ONLINE, CLICK HERE »

Or call 888-224-2480

You can save an extra 10% off the current rate by using code D10-999-JDS19.

Come to network and benchmark with top life sciences industry patent and intellectual property counsel.

ACI’s 17th Global Summit on Life Sciences Patents returns to New York in May to provide practical insights on how to maximize your patent term and develop strategies to enhance protections for your patent portfolio.

By bringing the collective knowledge and practical experiences of leading in-house IP counsel, patent prosecutors and litigators, the USPTO, and policy experts from both sides of the Atlantic, this event will provide you with comprehensive knowledge and benchmarking opportunities to ensure that you are leading the way in patent protection for your company and clients.

Download the conference brochure here »

Insights from the USPTO:

Keynote Address: The PTAB’s Latest Priorities, Review Procedures and What’s New for IPR

(TBA)
Chief Judge
PTAB

Analyses of New Developments in Obviousness-Type Double Patenting

Mary Till
Senior Legal Advisor
USPTO United States Patent and Trademark Office

Insights from Key Industry Leaders:

Karine Crepin
VP Head of Biologics Patents
Sanofi

Dr. Leslie Fischer
Principle Patent Attorney
Novartis Pharmaceuticals Corporation

Henry Gu
Head of Intellectual Property
Akebia Therapeutics

James Hayles
European Patent Attorney
Pfizer

Melodie Henderson
VP Intellectual Property
Sigilon Therapeutics

Immac J. Thampoe (“Casey”)
Assistant General Counsel – IP Portfolio Development
Regeneration Pharmaceuticals Inc.

Nicole Woods
Vice President – Assistant General Patent Counsel
Lilly Oncology

Yang Xu
Assistant General Counsel, IP
BeiGene Ltd.

Meet All the Speakers »

Why This Event Is A Must-Attend for You and Your Team:

• Network and benchmark with a “who’s who” of the life sciences patents community.
  • Our unparalleled faculty features over 15 in-house counsel — including new faces from Sanofi, Pfizer, Novartis, Novo Nordisk Inc, Eli Lilly, and BeiGene Ltd. They will share practical methodologies that have worked for them in recent prosecution proceedings and provide specific advice on how to cost-effectively protect your patent portfolio.

• Benefit from direct insights from the USPTO.
  • Hear from current and former USPTO insiders who will provide insights to help you perfect your prosecution and defense strategies.

• Participate in sophisticated and practical sessions tailored to provide comprehensive updates and strategic solutions to a savvy audience.
  • Walk away with winning strategies you can immediately incorporate into your daily practice to address challenges with § 101 patentability, FTO searches, obviousness-type double patenting, and written description and indefiniteness.

• Obtain a globalized 360-degree view of Life Sciences Patent from the leaders setting the relevant standards.
  • From the U.S. to Europe, this event is unparalleled in bringing together not only an exceptional in-house presence on the faculty, but also lawyers from the top IP firms representing biotechnology and pharmaceutical companies who will share their perspectives on how to thrive in challenging times.

See the Complete Agenda here »

REGISTER NOW and save an extra 10% off the conference by using code D10-999-JDS19.

*Discount is valid for new registration only and it’s not applicable for workshops.